BioNexus Gene Lab Valuation

Is BGLC undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

1/6

Valuation Score 1/6

Below Fair Value
Significantly Below Fair Value
Price-To-Sales vs Peers
Price-To-Sales vs Industry
Price-To-Sales vs Fair Ratio
Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of BGLC when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: Insufficient data to calculate BGLC's fair value for valuation analysis.

Significantly Below Fair Value: Insufficient data to calculate BGLC's fair value for valuation analysis.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for BGLC?

Key metric: As BGLC is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.

The above table shows the Price to Sales ratio for BGLC. This is calculated by dividing BGLC's market cap by their current revenue.
What is BGLC's PS Ratio?
PS Ratio	0.6x
Sales	US$9.26m
Market Cap	US$5.39m

BGLC key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue	0.2x
Enterprise Value/EBITDA	-5.9x
PEG Ratio	n/a

Price to Sales Ratio vs Peers

How does BGLC's PS Ratio compare to its peers?

The above table shows the PS ratio for BGLC vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
Company	Forward PS	Estimated Growth	Market Cap
Peer Average	0.2x
AMMX AmeraMex International	0.4x	n/a	US$5.3m
FGI FGI Industries	0.06x	7.0%	US$7.8m
BYU BAIYU Holdings	0.07x	n/a	US$9.1m
MWG Multi Ways Holdings	0.2x	n/a	US$7.9m
BGLC BioNexus Gene Lab	0.6x	n/a	US$5.4m

Price-To-Sales vs Peers: BGLC is expensive based on its Price-To-Sales Ratio (0.6x) compared to the peer average (0.2x).

Price to Sales Ratio vs Industry

How does BGLC's PS Ratio compare vs other companies in the US Trade Distributors Industry?

6 Companies	Price / Sales	Estimated Growth	Market Cap
TITN Titan Machinery	0.1x	-1.8%	US$320.22m
ALTG Alta Equipment Group	0.1x	2.4%	US$247.76m
IPW iPower	0.3x	n/a	US$19.80m
BYU BAIYU Holdings	0.07x	n/a	US$9.09m

6 Companies		Estimated Growth	Market Cap

No more companies

Price-To-Sales vs Industry: BGLC is good value based on its Price-To-Sales Ratio (0.6x) compared to the US Trade Distributors industry average (1x).

Price to Sales Ratio vs Fair Ratio

What is BGLC's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

BGLC PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio	0.6x
Fair PS Ratio	n/a

Price-To-Sales vs Fair Ratio: Insufficient data to calculate BGLC's Price-To-Sales Fair Ratio for valuation analysis.

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.

Discover undervalued companies

Textron

US$15.1b

Operates in the aircraft, defense, industrial, and finance businesses worldwide.

TXT

US$81.86

-6.5%

4.9%

Mitsubishi

JP¥10.4t

Engages in the natural gas, industrial materials and infrastructure, chemicals, mineral resources, automotive and mobility, food and consumer industry, power solution, and urban development businesses worldwide.

MSBH.F

JP¥17.15

-2.0%

9.5%

NFI Group

CA$1.8b

Manufactures and sells buses in North America, the United Kingdom, rest of Europe, and the Asia Pacific.

NFYE.F

CA$10.45

-3.9%

3.1%